ARCHIVES

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

In Brief: NCI’s George Khoury Dies; Panel to Meet June 22 In Pittsburgh; Rosemary Mackey To Leave MDA

May 8, 1987

Low-Dose Aspirin Cuts Risk Of Colorectal Growths

April 26, 2002

Large Bowel Study Expansion Hampered By Lack Of Coordination, NCI Admits

May 17, 1974

Daniel Hayes Elected President of ASCO

December 12, 2014

NCAB Needs Focus, Strong Membership To Better Advise NCI, Chairman Rimer Says

September 22, 1995